Clinical trial
Efficacy of Volume Substitution and Insulin Therapy in Severe Sepsis (VISEP…
NCT00135473 · SepNet - Critical Care Trials Group, Other · Completed
Key facts
| NCT number | NCT00135473 |
|---|---|
| Title | Efficacy of Volume Substitution and Insulin Therapy in Severe Sepsis (VISEP Trial) |
| Official title | Prospective Randomized Multicenter Study on the Influence of Colloid vs Crystalloid Volume Resuscitation and of Intensive vs Conventional Insulin Therapy on Outcome in Patients With Severe Sepsis and Septic Shock |
| Lead sponsor | SepNet - Critical Care Trials Group, Other |
| Collaborators | German Federal Ministry of Education and Research B. Braun Melsungen AG Industry Novo Nordisk A/S HemoCue |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Severe Sepsis, Septic Shock |
| Intervention type | Drug |
| Interventions | 10% Hemohes® (10% Hydroxyethyl starch), Sterofundin® (Ringer lactate solution), Actrapid® (Insulin) |
| Enrollment | 600 |
| Start date | Apr 1, 2003 |
| Completion | Sep 1, 2005 |
| First posted | Aug 26, 2005 |
| Last update posted | Feb 11, 2016 |
| Countries | Germany |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: